Soleus Capital Management’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,362,026
Closed -$833K 100
2025
Q3
$833K Buy
4,362,026
+2,100,000
+93% +$2.52M 0.04% 80
2025
Q2
$3.85M Hold
2,262,026
0.27% 60
2025
Q1
$3.57M Hold
2,262,026
0.28% 55
2024
Q4
$4.05M Sell
2,262,026
-2,026,141
-47% -$6.45M 0.31% 57
2024
Q3
$26M Buy
4,288,167
+77,630
+2% +$426K 2.16% 15
2024
Q2
$22.1M Buy
4,210,537
+620,979
+17% +$3.95M 1.95% 16
2024
Q1
$30.5M Sell
3,589,558
-738,064
-17% -$6.44M 2.68% 10
2023
Q4
$28.6M Buy
4,327,622
+40,528
+0.9% +$200K 3.17% 10
2023
Q3
$13.2M Buy
4,287,094
+85,000
+2% +$245K 1.33% 30
2023
Q2
$11.3M Buy
4,202,094
+56,977
+1% +$167K 1.26% 22
2023
Q1
$12.3M Buy
4,145,117
+275,725
+7% +$810K 1.53% 23
2022
Q4
$9.75M Buy
3,869,392
+1,228,853
+47% +$3.53M 1.4% 25
2022
Q3
$4.81M Sell
2,640,539
-1,528,260
-37% -$4.03M 0.65% 43
2022
Q2
$13.1M Sell
4,168,799
-55,000
-1% -$307K 2.1% 13
2022
Q1
$26.1M Buy
4,223,799
+698,342
+20% +$6.14M 4.02% 3
2021
Q4
$50.1M Buy
3,525,457
+657,434
+23% +$7.32M 6.76% 4
2021
Q3
$22.9M Buy
2,868,023
+629,919
+28% +$10M 3.58% 7
2021
Q2
$63.9M Buy
2,238,104
+168,052
+8% +$4.88M 9.83% 2
2021
Q1
$60.1M Sell
2,070,052
-305,629
-13% -$7.1M 10.84% 2
2020
Q4
$28.3M Buy
2,375,681
+548,701
+30% +$3.86M 7.87% 3
2020
Q3
$12.6M Sell
1,826,980
-255,205
-12% -$1.73M 6.68% 1
2020
Q2
$12.9M Buy
2,082,185
+1,764
+0.1% +$8.36K 7.89% 2
2020
Q1
$8.32M Buy
2,080,421
+446,052
+27% +$2.24M 9.68% 1
2019
Q4
$8.99M Buy
+1,634,369
New +$7.6M 8.67% 2